Wróć

Wybierz swój region

Corporate

Europa:

Flaga Albania Albania Flaga Bośnia i Hercegowina Bośnia i Hercegowina Flaga Bułgaria Bułgaria Flaga Chorwacja Chorwacja Flaga Cypr Cypr Flaga Czarnogóra Czarnogóra Flaga Czechy Czechy Flaga Dania Dania Flaga Estonia Estonia Flaga Hiszpania Hiszpania Flaga Kosowo Kosowo Flaga Litwa Litwa Flaga Łotwa Łotwa Flaga Luksemburg Luksemburg Flaga Macedonia Macedonia Flaga Niemcy Niemcy Flaga Polska Polska Flaga Portugalia Portugalia Flaga Rumunia Rumunia Flaga Serbia Serbia Flaga Słowacja Słowacja Flaga Słowenia Słowenia Flaga Szwajcaria Szwajcaria Flaga Szwecja Szwecja Flaga Turcja Turcja Flaga Węgry Węgry Flaga Wielka Brytania Wielka Brytania Flaga Włochy Włochy

Azja:

Flaga UAE UAE Flaga Hong Kong Hong Kong Flaga Kuwejt Kuwejt Flaga Liban Liban

Afryka:

Flaga RPA RPA

Umów konsultację o krwi pępowinowej

Umawiam

Skontaktuj się z nami już dziś!

Chcesz dowiedzieć się więcej o naszych usługach? Uzupełnij poniższy formularz, a my skontaktujemy się z Tobą jak najszybciej, aby udzielić Ci wszelkich potrzebnych informacji oraz odpowiedzieć na Twoje pytania.

    Uprzejmie informujemy, że dane osobowe podane w formularzu będą przetwarzane przez Polski Bank Komórek Macierzystych Sp. z o.o. („PBKM”) z siedzibą w Warszawie, Al. Jana Pawła II 29 w celu kontaktu telefonicznego w związku z udzieleniem informacji na temat usługi.

    Zestawienie leczonych pacjentów

    Terapie
    komórkami macierzystymi

    Terapie komórkami macierzystymi

    Celem bankowania komórek macierzystych jest ich późniejsze wykorzystanie w terapii. Krew pępowinowa została zastosowana po raz pierwszy w 1988 roku, a od tego czasu – zgodnie z dostępnymi danymi – komórki macierzyste zostały użyte na świecie ponad 85 000 razy (łącznie ze statystykami z Chin).

    Grupa FamiCord przechowuje ponad 1 000 000 porcji komórek różnych typów i dostarczyła komórki macierzyste do zastosowań klinicznych dla ponad 7000 pacjentów. Dostarczamy komórki do standardowych przeszczepień (z krwi pępowinowej, szpiku kostnego i mobilizowanej krwi obwodowej) oraz do terapii komórkowych. Ponadto wytwarzamy produkty komórkowe w standardzie GMP (ang. Good Manufacturing Practice) do badań klinicznych.

    Komórki macierzyste pochodzące z naszych laboratoriów były wykorzystywane w leczeniu pacjentów z chorobami i wskazaniami z różnych obszarów terapeutycznych – m.in. hematologii, neurologii, okulistyki, ortopedii i dermatologii.

    Sprawdź pełną listę pacjentów, którzy otrzymali terapię komórkami macierzystymi pochodzącymi z laboratoriów Grupy FamiCord.

    Data aktualizacji: 06.2026

    Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord

    Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord
    Lp. Źródło Typ źródła Wskazanie Obszar medycyny Rok podania Terapia Kraj Wiek odbiorcy
    4601 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 58
    4602 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 67
    4603 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 47
    4604 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 56
    4605 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 55
    4606 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 64
    4607 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 66
    4608 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 65
    4609 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 63
    4610 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 69
    4611 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Poland 63
    4612 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2020 Standard Therapy Germany 73
    4613 Apheresis Allogeneic Myelofibrosis Hematology 2020 Standard Therapy Poland 63
    4614 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2020 Standard Therapy Poland 69
    4615 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2020 Standard Therapy Poland 70
    4616 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2020 Standard Therapy Poland 63
    4617 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2020 Standard Therapy Poland 62
    4618 Apheresis Allogeneic Myelofibrosis With Myeloid Metaplasia Hematology 2020 Standard Therapy Poland 43
    4619 Apheresis Allogeneic Myeloma Multiplex Hematology 2020 Standard Therapy Poland 63
    4620 Apheresis Allogeneic Myeloma Multiplex Hematology 2020 Standard Therapy Poland 52
    4621 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2020 Standard Therapy Poland 68
    4622 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2020 Standard Therapy Poland 40
    4623 Apheresis Allogeneic No Data Hematology 2020 Standard Therapy Poland 71
    4624 Apheresis Allogeneic No Data Hematology 2020 Standard Therapy Poland 64
    4625 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Poland 65
    4626 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Poland 58
    4627 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Poland 63
    4628 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Poland 58
    4629 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Poland 62
    4630 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Poland 53
    4631 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Poland 57
    4632 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Poland 69
    4633 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Poland 62
    4634 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Poland 34
    4635 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Germany 42
    4636 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Germany 62
    4637 Apheresis Autologous Non-Hodgkin-Lymphoma-Relapse Hematology 2020 Standard Therapy Germany 56
    4638 Apheresis Autologous Non-Hodgkin-Lymphoma-Relapse Hematology 2020 Standard Therapy Germany 67
    4639 Apheresis Allogeneic Osteomyelofibrosis Hematology 2020 Standard Therapy Poland 68
    4640 Apheresis Allogeneic Osteomyelofibrosis Hematology 2020 Standard Therapy Poland 52
    4641 Apheresis Allogeneic Osteomyelofibrosis Hematology 2020 Standard Therapy Poland 64
    4642 Apheresis Allogeneic Paroxysmal Nocturnal Hemoglobinuria (Pnh) Hematology 2020 Standard Therapy Poland 57
    4643 Apheresis Allogeneic Perforin Deficiency Hematology 2020 Standard Therapy Poland 2
    4644 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2020 Standard Therapy Germany 59
    4645 Apheresis Autologous Primary Cerebral Diffuse Large B-Cell Lymphoma Hematology 2020 Standard Therapy Germany 66
    4646 Apheresis Autologous Primary Cerebral Diffuse Large B-Cell Lymphoma Hematology 2020 Standard Therapy Germany 59
    4647 Apheresis Allogeneic Primary Myelofibrosis Hematology 2020 Standard Therapy Poland 63
    4648 Apheresis Allogeneic Primary Myelofibrosis Hematology 2020 Standard Therapy Poland 61
    4649 Apheresis Allogeneic Primary Myelofibrosis Hematology 2020 Standard Therapy Poland 51
    4650 Apheresis Allogeneic Primary Myelofibrosis Hematology 2020 Standard Therapy Poland 66
    4651 Apheresis Allogeneic Primary Myelofibrosis Hematology 2020 Standard Therapy Poland 61
    4652 Apheresis Allogeneic Primary Myelofibrosis Hematology 2020 Standard Therapy Germany 54
    4653 Apheresis Allogeneic Primary Myelofibrosis Hematology 2020 Standard Therapy Germany 58
    4654 Apheresis Allogeneic Purine Nucleoside Phosphorylase Deficiency Hematology 2020 Standard Therapy Poland 1
    4655 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 43
    4656 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 76
    4657 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2020 Standard Therapy Poland 57
    4658 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2020 Standard Therapy Germany 66
    4659 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2020 Standard Therapy Germany 56
    4660 Apheresis Autologous Secondary B-Cell Non-Hodgkin-Lymphoma Hematology 2020 Standard Therapy Germany 73
    4661 Apheresis Autologous Secondary Diffuse Large B-Cell Lymphoma Hematology 2020 Standard Therapy Germany 54
    4662 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2020 Standard Therapy Poland 9
    4663 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2020 Standard Therapy Poland 53
    4664 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2020 Standard Therapy Poland 52
    4665 Apheresis Allogeneic Severe Combined Immunodeficiency Hematology 2020 Standard Therapy Poland 2
    4666 Apheresis Allogeneic Sezary Syndrome Hematology 2020 Standard Therapy Poland 44
    4667 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2020 Standard Therapy Poland 14
    4668 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Germany 57
    4669 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Germany 29
    4670 Apheresis Autologous T-Cell Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Germany 64
    4671 Apheresis Allogeneic T-Cell Non-Hodgkin Lymphoma Hematology 2020 Standard Therapy Germany 63
    4672 Apheresis Allogeneic T-Cell-Lymphoma Hematology 2020 Standard Therapy Poland 29
    4673 Apheresis Autologous T-Cell-Lymphoma Hematology 2020 Standard Therapy Germany 51
    4674 Apheresis Autologous T-Cell-Lymphoma Hematology 2020 Standard Therapy Germany 60
    4675 Apheresis Allogeneic T-Cell-Prolymphocytic Leukemia Hematology 2020 Standard Therapy Poland 55
    4676 Apheresis Allogeneic T-Cell-Prolymphocytic Leukemia Hematology 2020 Standard Therapy Poland 74
    4677 Apheresis Allogeneic Β – Thalassemia Hematology 2020 Standard Therapy Poland 6
    4678 Apheresis Allogeneic Β – Thalassemia Major Hematology 2020 Standard Therapy Poland 17
    4679 Adipose Tissue Autologous Alopecia Dermatology 2020 Experimental Therapy Poland 68
    4680 Adipose Tissue Autologous Chondromalacia Orthopedy 2020 Experimental Therapy Poland 45
    4681 Adipose Tissue Autologous Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 52
    4682 Adipose Tissue Autologous Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 63
    4683 Adipose Tissue Autologous Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 41
    4684 Adipose Tissue Autologous Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 34
    4685 Adipose Tissue Autologous Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 48
    4686 Adipose Tissue Autologous Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 57
    4687 Adipose Tissue Autologous Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 59
    4688 Adipose Tissue Autologous Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 35
    4689 Adipose Tissue Autologous Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 61
    4690 Adipose Tissue Autologous Gonarthrosis Orthopedy 2020 Experimental Therapy Poland 56
    4691 Adipose Tissue Autologous Gonarthrosis; Shoulder Osteoarthritis Orthopedy 2020 Experimental Therapy Poland 42
    4692 Adipose Tissue Autologous Internal Damage To The Knee Joint Orthopedy 2020 Experimental Therapy Poland 53
    4693 Adipose Tissue Autologous Internal Damage To The Knee Joint Orthopedy 2020 Experimental Therapy Poland 49
    4694 Adipose Tissue Autologous Omarthrosis Orthopedy 2020 Experimental Therapy Poland 70
    4695 Adipose Tissue Autologous Other Acquired Deformities Of The Ankle And Foot Orthopedy 2020 Experimental Therapy Poland 41
    4696 Adipose Tissue Autologous Scar Dermatology 2020 Clinical Trial Poland 0
    4697 Adipose Tissue Autologous Soft Tissue Diseases Related To Use, Overload And Pressure Orthopedy 2020 Experimental Therapy Poland 61
    4698 Cord Tissue Allogeneic – Unrelated Limb-Girdle Muscular Dystrophy Neurology 2019 Experimental Therapy Poland 5
    4699 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2019 Experimental Therapy Poland 1
    4700 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2019 Experimental Therapy Poland 6